|
Volumn 65, Issue 1, 2002, Pages 16-20
|
Symplostatin 3, a new dolastatin 10 analogue from the marine cyanobacterium Symploca sp. VP452
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DOLASTATIN 10;
SYMPLOSTATIN 3;
UNCLASSIFIED DRUG;
ARTICLE;
CARBOXY TERMINAL SEQUENCE;
CORRELATION ANALYSIS;
CYANOBACTERIUM;
CYTOTOXICITY;
DRUG ISOLATION;
DRUG MECHANISM;
DRUG STRUCTURE;
HUMAN;
HUMAN CELL;
IC 50;
MICROTUBULE;
STRUCTURE ANALYSIS;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
CYANOBACTERIA;
DEPSIPEPTIDES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG SCREENING ASSAYS, ANTITUMOR;
FIBROBLASTS;
HAWAII;
HUMANS;
INHIBITORY CONCENTRATION 50;
KB CELLS;
LEUKEMIA L1210;
MASS SPECTROMETRY;
MICE;
MICROSCOPY, FLUORESCENCE;
MICROTUBULES;
MOLECULAR STRUCTURE;
NEOPLASMS;
NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR;
OLIGOPEPTIDES;
SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;
STRUCTURE-ACTIVITY RELATIONSHIP;
THIAZOLES;
TUMOR CELLS, CULTURED;
HAWAIIA;
STAPHYLOCOCCUS PHAGE 3A;
SYMPLOCA;
|
EID: 0036165655
PISSN: 01633864
EISSN: None
Source Type: Journal
DOI: 10.1021/np010317s Document Type: Article |
Times cited : (91)
|
References (34)
|